GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HitGen Inc (SHSE:688222) » Definitions » Additional Paid-In Capital

HitGen (SHSE:688222) Additional Paid-In Capital : ¥748.6 Mil(As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is HitGen Additional Paid-In Capital?


HitGen's quarterly additional paid-in capital declined from Dec. 2023 (¥748.6 Mil) to Mar. 2024 (¥0.0 Mil) but then increased from Mar. 2024 (¥0.0 Mil) to Jun. 2024 (¥748.6 Mil).

HitGen's annual additional paid-in capital increased from Dec. 2021 (¥748.0 Mil) to Dec. 2022 (¥748.6 Mil) but then stayed the same from Dec. 2022 (¥748.6 Mil) to Dec. 2023 (¥748.6 Mil).


HitGen Additional Paid-In Capital Historical Data

The historical data trend for HitGen's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HitGen Additional Paid-In Capital Chart

HitGen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 39.29 744.62 747.98 748.59 748.59

HitGen Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 748.59 - 748.59 - 748.59

HitGen Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

HitGen Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of HitGen's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


HitGen Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 18, Section 2, Biocity Middle Road, Chengdu Tianfu International Biological City, Shuangliu District, Sichuan Province, Chengdu, CHN, 610093
HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.

HitGen Headlines

No Headlines